Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Nov-Dec;14(6):461-467.
doi: 10.21873/cgp.20056.

DHPLC Elution Patterns of VDR PCR Products Can Predict Prostate Cancer Susceptibility in African American Men

Affiliations
Review

DHPLC Elution Patterns of VDR PCR Products Can Predict Prostate Cancer Susceptibility in African American Men

Robert L Copeland et al. Cancer Genomics Proteomics. 2017 Nov-Dec.

Abstract

Background/aim: Denaturing high-performance liquid chromatography (DHPLC) is a technique that is used to detect mutations. The aim of the present study was to determine whether DHPLC elution patterns of vitamin D receptor (VDR) gene PCR products can serve as indicators of susceptibility to prostate cancer (PCa) risk.

Materials and methods: DNA samples of PCa cases and controls were screened for mutations and/or polymorphisms in coding exons of VDR gene using DHPLC analysis. Logistic regression, phi-coefficient (ϕ), and Backward Wald models were used to analyze the data.

Results: Similar elution patterns of exons 1, 6, 7 and 9 along with higher prevalence of heteroduplex DNA were observed in PCa samples than in controls. Exons 4 and 8 had highly significant protective effects (p<0.05). Whereas, exons 5, 7, and 9 were perfectly positively correlated with PCa risk (ϕ=1), thus presenting candidate exons significantly associated with susceptibility to PCa.

Conclusion: DHPLC elution patterns of the selected exons could be useful to predict susceptibility to develop PCa.

Keywords: African American men; Prostate cancer; vitamin D; vitamin D receptor gene.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Haas GP, Delongchamps N, Brawley OW, Wang CY, de La Roza G. The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Can J Urol. 2008;15(1):3866–3871. - PMC - PubMed
    1. Wong MCS, Goggins WB, Wang HHX, Fung FDH, Leung C, Wong SYS, Ng CF. Global Incidence an Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries. Eur Urol. 2016;70(5):862–874. - PubMed
    1. Shui I, Giovannucci E. Vitamin D status and cancer incidence and mortality. Adv Exp Med Biol. 2014;810:33–51. - PubMed
    1. Schuurman AG, Zeegers MP, Goldbohm RA, van den Brandt PA. A case-cohort study on prostate cancer risk in relation to family history of prostate cancer. Epidemiology. 1999;10(2):192–195. - PubMed
    1. Ekman P, Pan Y, Li C, Dich J. Environmental and genetic factors: a possible link with prostate cancer. Br J Urol Suppl. 1997;2:35–41. - PubMed

LinkOut - more resources